Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 3/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.47 |
| ▸ | FAAH | O00519 | 2/20 | 0.44 |
| ▸ | RECQL | P46063 | 2/20 | 0.43 |
| ▸ | EPHX2 | P34913 | 4/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | THRB | P10828 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | ACHE | P22303 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23511352 | 1.00 | MEN1 (0.47) | MEN1KMT2AFAAHRECQLEPHX2 | |
| SCHEMBL23511351 | 0.87 | FAAH (0.53) | FAAHRECQLEPHX2ALDH1A1SMN1; SMN2 | |
| SCHEMBL20438874 | 0.87 | MEN1 (0.57) | MEN1KMT2AFAAHRECQLEPHX2 | |
| SCHEMBL26230280 | 0.86 | FAAH (0.45) | MEN1KMT2AFAAHRECQLEPHX2 | |
| SCHEMBL18594579 | 0.86 | FAAH (0.59) | FAAHEPHX2ALDH1A1MAPT | |
| SCHEMBL25446256 | 0.84 | FAAH (0.50) | FAAHRECQLEPHX2ALDH1A1SMN1; SMN2 | |
| SCHEMBL18772401 | 0.84 | FAAH (0.67) | FAAHEPHX2ALDH1A1MAPT | |
| SCHEMBL16154939 | 0.84 | FAAH (0.43) | FAAHRECQLEPHX2ALDH1A1TSHR | |
| SCHEMBL25831070 | 0.84 | MEN1 (0.52) | MEN1KMT2AFAAHRECQLEPHX2 | |
| SCHEMBL22374761 | 0.84 | FAAH (0.38) | MEN1KMT2AFAAHRECQLEPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11986480-B2 | Heterocyclic compound | TOHOKU UNIVERSITY (JP) | 2024-05-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11986480-B2 | Heterocyclic compound | SQSTM1, BECN1, ATG7 | MEN1 3191/4885KMT2A 3485/4885FAAH 4127/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.